Literature DB >> 16221113

The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin.

Carol Pollock, Lawrence McMahon.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16221113     DOI： 10.1111/j.1440-1797.2005.00466.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN： 1320-5358            Impact factor:   2.506


× No keyword cloud information.
  5 in total

1.  C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.

Authors:  Iain C Macdougall; Rowan Walker; Robert Provenzano; Fernando de Alvaro; Harold R Locay; Paul C Nader; Francesco Locatelli; Frank C Dougherty; Ulrich Beyer
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

2.  Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the IDEAL trial.

Authors:  David W Johnson; Muh Geot Wong; Bruce A Cooper; Pauline Branley; Liliana Bulfone; John F Collins; Jonathan C Craig; Margaret B Fraenkel; Anthony Harris; Joan Kesselhut; Jing Jing Li; Grant Luxton; Andrew Pilmore; David J Tiller; David C Harris; Carol A Pollock
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

3.  [Predictors of response to the CERA in chronic hemodialysis treatment-naive by erythropoiesis-stimulating agent].

Authors:  Mariam Ezziani; Adil Najdi; Souad Mikou; Hakim Hanin; Mohammed Arrayhani; Tarik Sqalli Houssaini
Journal:  Pan Afr Med J       Date:  2015-04-07

4.  Individualizing anaemia therapy.

Authors:  Angel L M de Francisco
Journal:  NDT Plus       Date:  2010-09-21

Review 5.  Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).

Authors:  Usha Panchapakesan; Siska Sumual; Carol Pollock
Journal:  Int J Nanomedicine       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.